UN health R&D summit 'leaves the greater part of the job undone.' MSF's Statement at the close of the UN Health R&D Summit
Food Crisis Campaign director talks to the BBC about the food crisis and highlights children's special nutritional needs

Charles, two and half years old, died recently. He'd been brought to the MSF clinic in Mathare, infamous as the poorest slum in Kenya. He was HIV positive and also infected with tuberculosis (TB). Here in Kenya, like elsewhere in Africa and throughout the developing world, we are struggling to treat patients with inadequate medical tools. Dr Liesbet Ohler berates a system that has failed to deliver the medicines that might have saved Charles and could save millions more. Click here
New Drug Trials for Drug-Resistant TBIn a series of papers published by PLoS, international experts explain how innovative trials in patients with drug resistant TB could speed up delivery of new drugs, explore how to fill up the current TB pipeline with additional promising drugs and call for building of clinical trial capacity in developing countries. Paper on Randomized drug trials |
Treating drug resistant TB in Uzbekistan
In Karakalpakstan, a semi-autonomous region of Uzbekistan, MSF works with the local health authorities to treat patients with MDR TB. Recent results have thrown up some alarming statistics about the spread of an even more resistant strain of TB – extensively drug resistant TB or XDR TB click here. to listen to Dr Kai Braker, MSF 's medical advisor to the project. |
Dying for a Test
Martine Usdin, biologist with the MSF Access Campaign explains what needs to be done to improve TB diagnostics now and in the future. Click here Click here to read MSF's analysis of the TB diagnostics pipeline
Tuberculosis in China
One quarter of the world's TB cases are in China and drug resistant TB is on the rise. Click here to read more about TB in China |
MSF and Tuberculosis |
The Hospital on the Edge of Town: Treating MDR TB in Karakalpakstan